Eli Lilly News

20.11 / 11:15

Target Immunic vaccine testing volunteers patient prevention Vaccines Researchers return to Alzheimer's vaccines, buoyed by recent drug success

By Julie Steenhuysen

17.11 / 18:29

Reuters Manufacturing Racing Coronavirus Healthcare reports patient Lilly to build $2.5 billion Germany plant as obesity drug demand soars

By Klaus Lauer and Ludwig Burger

17.11 / 18:09

Provident Manufacturing CEO Gap Nov Sky News track reports Midday movers: Gap, Applied Materials, ChargePoint and more

Investing.com — U.S. are wobbling on Friday but were still on track for a weekly gain. Cautious words from retailers about the holiday sales season and hopes that the Federal Reserve is nearing the end of its interest rate increases are on the minds of investors.

16.11 / 19:47

Reuters Manufacturing Bill reports Department Midday movers: Walmart, Macy's, Alibaba, Cisco and more

Investing.com — U.S. stocks were falling as the steam ran out of their recent rally after Walmart's cautious outlook on consumer spending.

16.11 / 13:39

Ripple Pfizer Amgen Experts show reports Big Pharma scrambles to feed demand for weight-loss treatments

Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world’s biggest drug developers are tapping into the growing treatment market

15.11 / 12:15

President show country social reports patient Germany mulls export ban on Novo Nordisk’s Ozempic amid global shortage of weight-loss drugs: report

weight-loss drugs, said a report by Der Spiegel magazine. Ozempic has been approved to treat type 2 diabetes but has also been prescribed “off-label" to treat weight loss because it has the same active ingredient as Novo's hugely popular anti-obesity drug Wegovy. The two Novo drugs can help people shed about 15% of their weight.

13.11 / 10:25

Coca-Cola Manufacturing CEO PepsiCo Intuit show patient Factbox-Corporate America weighs business impact of new weight-loss drugs

(Reuters) -U.S. companies across sectors such as food and beverage makers and manufacturers of glucose monitors are facing investor questions over the risk to future sales from the growing popularity of promising weight-loss treatments.

09.11 / 14:21

Reuters Healthcare medicines Eli Lilly: still seeking UK approval on pen for weight-loss drug

By Maggie Fick and Ludwig Burger

09.11 / 04:53

Target Experts Celebrity social hospital testing medicines FDA approves new version of diabetes drug Mounjaro for weight loss

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug

09.11 / 01:23

Provident Patrick Morningstar Healthcare patient medicines Lilly weight-loss drug Zepbound gets US, UK approval to rival Wegovy

By Patrick Wingrove and Bhanvi Satija

02.11 / 12:17

Racing Healthcare reports patient Q3 Lilly cuts annual profit view on M&A charges; Mounjaro boosts Q3 sales

(Reuters) -Eli Lilly on Thursday cut its annual profit outlook on charges related to recent acquisitions, and beat quarterly sales estimates driven by strong demand for its new blockbuster diabetes drug, Mounjaro.

02.11 / 12:17

Art Parke Moderna Qualcomm electronic reports travelers fall Starbucks, DoorDash, Roku, Qualcomm rise premarket; Peloton, Moderna fall

Investing.com — U.S. futures climbed higher Thursday, as investors took confidence in Fed Chair Jerome Powell’s comments, hoping that U.S. interest rates have now peaked.

02.11 / 07:35

Cardiovascular show reports patient Novo Nordisk posts record quarterly results, keeps curbs on Wegovy supplies

By Jacob Gronholt-Pedersen

30.10 / 13:05

Manufacturing Apple Moderna MSCI Nikkei show reports Stocks gain, oil falls, traders focus on rates outlook

By Elizabeth Howcroft

30.10 / 13:05

Provident Caterpillar Apple McDonald’s cover reports testing 500 Weekly Dow Jones, Nasdaq, S&P 500 weekly preview: Fed, Apple and NFP in spotlight

The bears had a relatively easy time last week as high yields, ongoing geopolitical risks, strong economic data, and, most importantly, disappointing earnings all worked in their favor.

20.10 / 14:27

COST Reuters Intuit reports patient medicines Medical device makers see limited hit from weight-loss drugs

(Reuters) — U.S. medical device makers do not see a big impact of new weight-loss treatments on the sales of equipment used in procedures such as bariatric surgery due to the prohibitive costs of the drugs as well as reimbursement hurdles.

17.10 / 12:03

UPS Ford CEO Parke awards Bill donates Courts Those New Pickleball Courts? Thank Ozempic.

The Indianapolis Motor Speedway Museum just got $20 million to build a high-tech classroom for visiting students. The source: weight-loss drug wealth. Two nonprofit foundations are large shareholders of Eli Lilly and Novo Nordisk, the companies selling the drugs Ozempic, Wegovy and Mounjaro popularly used to reduce weight.

16.10 / 13:35

Target Experts show hospital reports Department medicines Drug used in diabetes treatment Mounjaro helped dieters shed 60 pounds, study finds

A new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight

11.10 / 18:01

CEO Mobile Baxter Coherent Amgen DaVita Fresenius Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more

Check out the companies making big moves midday.

09.10 / 13:05

UPS Reuters Mobile Shell reports Bristol-Myers Squibb shells out billions for Mirati: 5 big deal reports

Investing.com — Here is your Pro Recap of 5 head-turning deal dispatches you may have missed last week: deals at Bristol Myers Squibb/Mirati Therapeutics, Eli Lilly/Point Biopharma, Suncor Energy/TotalEnergies, deal talks at Exxon Mobil/Pioneer Natural Resources, and potential sale of EngageSmart.

03.10 / 16:49

COST Manufacturing show pop reports travelers Stocks making the biggest moves midday: Meta, Warby Parker, McCormick and more

Check out the companies making headlines in midday trading.

information about Eli Lilly

Who is Eli Lilly?

Eli Lilly is a public personality featured in various informative articles related to recent developments.

Why is Eli Lilly attracting attention?

Eli Lilly frequently draws public interest due to widely discussed behavior, which raises concern among experts and the public.

Where can I find the latest news about Eli Lilly?

Our website has a dedicated section featuring all recent updates related to Eli Lilly. We continuously monitor developments and update the information as it becomes available.